The Valley Desk

NCT01594216 · Interventional trial

Ruxolitinib in Estrogen Receptor Positive Breast Cancer

Overall registry status Completed

Phase 2

Conditions Estrogen-receptor Positive Invasive Metastatic Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov